SecBot SecBot
8-K ·Filed Nov 12, 2026

NPCE

NeuroPace Inc
BEARISH
Impact 6/10
Horizonweeks Processed5d 1h ago SEC0001528287-26-000037
8-K Item 2.02: Earnings release
Actionable Insight ▼ Bearish

The revenue miss and guidance cut signal a material deceleration in the core RNS business. Watch for Q4 scheduled case recovery and the IGE PMA-S amendment submission around year end as key catalysts. The positive Adjusted EBITDA milestone provides some cost structure confidence but does not offset the top-line disappointment.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$7.56
T+0 close · Nov 12, 2026 · via day close
Latest settled
+5.42%
T+1 · $7.97
Vs SPY
+7.33%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $7.56entry
  2. T+1 · yesterday +5.42%α +7.33% · $7.97
  3. T+2 · todayOpen
  4. T+5 · in 3d Pending
  5. T+20 · in 27d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

NeuroPace reported Q3 2026 total revenue of $23.1M, down 1.1% YoY, and RNS System revenue growth of only 1.4%, well below prior expectations. The company slashed full-year 2026 revenue guidance to $91M-$92M from $99.5M-$101.5M, citing isolated account-level issues and field organization disruption. GAAP net loss improved to ($3.3M) from ($4.9M) a year ago, and the company achieved positive non-GAAP income from operations of $0.4M for the first time.

Key Financial Metrics

Revenue
$23.1M
est $27.2M · -15.1% · -1.1% YoY
Guidance
$91M-$92M
lowered
Gross Margin
84.3%

Key Facts

  • Q3 2026 total revenue $23.1M, down 1.1% YoY from $23.4M
  • RNS System revenue $22.9M, growth of only 1.4% YoY
  • Full-year 2026 revenue guidance revised to $91M-$92M from $99.5M-$101.5M
  • Adjusted EBITDA turned positive at $0.4M vs ($1.3M) in Q3 2025
  • Non-GAAP gross margin improved to 84.8% from 82.8%
  • Cash and investments $49.5M at quarter end, down from $51.9M prior quarter
  • IGE PMA-S amendment submission expected around year end after FDA SIR meeting
  • Remote Care PMA-S submitted to FDA with 180-day review cycle

Financial Impact

Revenue guidance cut by ~$9M (9%) at the midpoint; Q3 revenue missed consensus by ~$4.1M (15%)

revenueguidancegrowth rate

Segment Breakdown

SegmentRevenueGrowth
RNS System$22.9M+1.4%
Service$203.0KNot reported

Risk Factors

  • Revenue growth deceleration to 1.4% from historical 20%+ rates
  • Full-year guidance cut of ~$9M at midpoint
  • Field organization disruption may persist into Q4
  • IGE indication expansion timeline uncertain after SIR meeting
  • Cash burn continues with $49.5M in liquidity

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001528287-26-000037
Document: npce-20261112.htm0001528287-26-000037
Document: 0001528287-26-000037-index-headers.html0001528287-26-000037
Document: 0001528287-26-000037-index.html0001528287-26-000037
Document: 0001528287-26-000037.txt0001528287-26-000037
8-K Data (Synthetic)0001528287-26-000037

Track record

6 reports on NPCE

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 17, 2026today Insider Cluster Bullish 4/10 Entry $8.27 Now $8.20 −0.85% settles Nov 19
  2. Nov 17, 2026today Insider Buy Neutral 3/10 Entry $8.36 Now $8.20 −1.91% settles Nov 19
  3. Nov 12, 20265d ago 8-K Bearish 6/10 Viewing Entry $7.56 to $7.97 Now $8.20 −8.47% ▼ −5.42% −7.33% vs SPY
  4. Nov 9, 20267d ago Institutional Cluster Neutral 2/10 Entry $12.69 to $12.52 Now $8.20 −35.38% ▼ −1.34% −2.66% vs SPY
  5. May 12, 202627w ago 8-K Bullish 7/10 Entry $15.81 to $15.81 Now $8.20 −48.13% · 0.00% +0.00% vs SPY
  6. Apr 21, 202630w ago DEFA14A Neutral 3/10 Entry $16.98 to $16.87 Now $8.20 −51.71% ▼ −0.65% −0.25% vs SPY
Showing 6 of 6

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026